WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal, and subcutaneous injections in health-care settings

This guideline provides global, evidence-based recommendations on the use of safety-engineered injection devices to prevent the reuse of syringes and/or prevent needle-stick injuries in health-care workers. The ultimate aim is to make injection practices safer for patients and health-care workers an...

Full description

Bibliographic Details
Corporate Author: World Health Organization
Format: eBook
Language:English
Published: Geneva World Health Organization [2015], 2015
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02168nam a2200277 u 4500
001 EB001840268
003 EBX01000000000000001004257
005 00000000000000.0
007 tu|||||||||||||||||||||
008 180702 r ||| eng
245 0 0 |a WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal, and subcutaneous injections in health-care settings  |h Elektronische Ressource 
260 |a Geneva  |b World Health Organization  |c [2015], 2015 
300 |a 1 PDF file (32 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Equipment Safety / standards 
653 |a Needlestick Injuries / prevention & control 
653 |a Syringes / standards 
653 |a Hepatitis, Viral, Human / prevention & control 
653 |a Injections / standards 
710 2 |a World Health Organization 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
500 |a Title from PDF cover. - "WHO/HIS/SDS/2015.5." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK305368  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 140 
520 |a This guideline provides global, evidence-based recommendations on the use of safety-engineered injection devices to prevent the reuse of syringes and/or prevent needle-stick injuries in health-care workers. The ultimate aim is to make injection practices safer for patients and health-care workers and to prevent the injection-related transmission of deadly viruses, particularly HIV, Hepatitis C and Hepatitis B. The procedures covered are intramuscular (IM), intradermal (ID) and subcutaneous (SC) injections including the syringes needed for the reconstitution of medication or vaccines when required. Other procedures e.g. intravenous injections and infusions, blood collection for laboratory testing, and capillary blood sampling will be covered by another guideline to be issued separately by WHO. The policy recommendation aims to support Member States (MS) and development partners in making informed decisions on the appropriateness of introducing safety-engineered syringes for all injections in health-care settings